Year To Quarter End Statement Of Income

Oncolys BioPharma Inc. - Filing #7712870

Concept 2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
Year to quarter end statement of income
Statement of income
Net sales
JPY
15,938,000 JPY
168,549,000 JPY
152,611,000 JPY
168,549,000 JPY
229,139,000 JPY
196,552,000 JPY
JPY
229,139,000 JPY
32,586,000 JPY
Gross profit (loss)
47,217,000 JPY
157,581,000 JPY
Selling, general and administrative expenses
1,294,781,000 JPY
1,235,970,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
97,047,000 JPY
88,035,000 JPY
Taxes and dues
63,557,000 JPY
66,314,000 JPY
Operating profit (loss)
-593,210,000 JPY
-169,734,000 JPY
-654,353,000 JPY
-484,618,000 JPY
-1,247,563,000 JPY
-541,734,000 JPY
-438,213,000 JPY
-536,655,000 JPY
-1,078,389,000 JPY
-103,521,000 JPY
Non-operating income
Interest income
21,380,000 JPY
3,887,000 JPY
Dividend income
4,000 JPY
4,000 JPY
Non-operating income
21,415,000 JPY
3,920,000 JPY
Non-operating expenses
Interest expenses
2,797,000 JPY
3,274,000 JPY
Non-operating expenses
3,957,000 JPY
12,716,000 JPY
Ordinary profit (loss)
-1,230,105,000 JPY
-1,087,185,000 JPY
Profit (loss) before income taxes
-1,230,105,000 JPY
-1,087,185,000 JPY
Income taxes - current
3,740,000 JPY
3,518,000 JPY
Income taxes
3,740,000 JPY
3,518,000 JPY
Profit (loss)
-1,233,846,000 JPY
-1,233,846,000 JPY
-1,233,846,000 JPY
-1,233,846,000 JPY
-1,090,703,000 JPY
-1,090,703,000 JPY
-1,090,703,000 JPY
-1,090,703,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.